Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 7.71M | $12.0M | -- | +7.69M | 2026-06-30 |
| ADAR1 Capital Management, LLC | 926.4K | $14.0M | 17.46% | +905.8K | 2026-06-30 |
| FMR LLC | 794.7K | $12.0M | 14.98% | +1.3K | 2026-06-30 |
| VIKING GLOBAL INVESTORS LP | 524.3K | $8.0M | 9.88% | -- | 2026-06-30 |
| TPG GP A, LLC | 378.6K | $6.0M | 7.13% | -- | 2026-06-30 |
| Pivotal bioVenture Partners Investment Advisor LLC | 300.6K | $4.0M | 5.66% | -- | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 199.9K | $3.0M | 3.77% | +43.4K | 2026-06-30 |
| Nantahala Capital Management, LLC | 188.4K | $3.0M | 3.55% | -112.2K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 172.5K | $2.0M | 3.25% | +60.5K | 2026-06-30 |
| Almitas Capital LLC | 120.7K | $1.0M | 2.27% | -70.5K | 2026-06-30 |
